2002 Levine Symposium- Advances in Islet Cell Biology

描述（由申请人提供）：Rachmiel Levine，负责阐明胰岛素作用本质的科学家，被认为是现代糖尿病研究之父。每年，希望之城国家医疗中心都会举办为期三天的糖尿病研讨会，以纪念他。研讨会的重点每年都在变化，今年的研讨会主题为“胰岛细胞生物学进展：从干细胞分化到临床移植”。会议旨在全面介绍该领域的最新进展。具体而言，2002年莱文研讨会将提出专门讨论以下问题的会议：β细胞的功能发育和调节，β细胞功能中的遗传和免疫因素，胰岛细胞信号网络和功能反应，β细胞分化，胰岛基因表达和基因工程，胰岛干细胞分化，胰岛制备进展，胰岛自身免疫和免疫耐受诱导，胰岛移植的监管方面和资金，以及胰岛移植的临床有效性。预计会议将吸引与会者，从该领域的知名科学家到对该主题兴趣初露端倪的年轻调查人员。在前几年，莱文研讨会吸引了多达400名与会者。然而，由于手头的主题的重要性，今年的计划预计将吸引来自美国和国外的更多与会者。2002年莱文研讨会将于2002年10月9日至12日在加州阿纳海姆的阿纳海姆希尔顿酒店举行。除了提供来自领先科学家和临床医生的讲座外，今年的会议议程还开发了其他一些新功能，包括： （a）卫星会议时间为第1天晚上和第2天至第4天上午。 B）每天在午休时间举行“会见教授”会议，使研究人员和新来者能够与该领域的知名科学家进行互动，以获得指导和澄清。当天的演讲者将被要求作为这些午餐时间会议的教师。 c）第二天晚上为一组年轻调查员（约50人）举办海报展示会，介绍他们的工作。已经由国家档案和记录委员会资助的旅费赠款将提供给前10名演讲者，以鼓励他们的职业发展。一个由12名成员组成的项目主持委员会将根据数据的质量以及所提出概念的新奇和重要性来选择获奖者。本申请是为了请求2002年莱文糖尿病研讨会的教育补助金而提交的。

DESCRIPTION (provided by applicant): Rachmiel Levine, the scientist responsible for clarifying the nature of insulin action, is considered one of the fathers of modern diabetes research. Each year the City of Hope National Medical Center holds a three-day diabetes symposium in his memory. The focus of the symposium changes each year, and this year's symposium is entitled "Advances in Islet Cell Biology: From Stem Cell Differentiation to Clinical Transplantation". The meeting is designed to provide a comprehensive and up-to-date presentation on new advances in the field. Specifically, the 2002 Levine Symposium will present sessions dedicated to the following: Functional Development and Regulation of Beta Cells, Genetic and Immunologic Factors in Beta Cell Function, Islet Cell Signaling Network and Functional Response, Beta Cell Differentiation, Islet Gene Expression and Genetic Engineering, Islet Stem Cell Differentiation, Advances in Islet Preparation, Islet Autoimmunity and Immune Tolerance Induction, Regulatory Aspects and Funding of Islet Transplantation, and Clinical Effectiveness of Islet Transplantation. The meeting is expected to attract participants ranging from well-established scientists in the field to young investigators with a budding interest in the topic. In prior years, the Levine Symposium has attracted up to 400 attendees. However, due to the magnitude of the topic at hand, this year's program is expected to attract a larger number of attendees from both the U.S. and abroad. The 2002 Levine Symposium will be held on October 9-12, 2002 at the Anaheim Hilton Hotel, in Anaheim, California. In addition to providing lectures from leading scientists and clinicians, several other novel features have been developed for this year's meeting agenda, including: a) Satellite meeting hours the evening of day 1 and the mornings of days 2 through 4. b) Daily "Meet the Professor" sessions during the lunch breaks to allow investigators and newcomers to interact with established scientists in the field for guidance and clarification. The speakers of the day will be asked to function as the faculty for these lunch time sessions. c) A poster session on the evening of day 2 for a group of young investigators (approximately 50) to present their work. Travel grants, already funded by the NCRR, will be made available to each of the top 10 presenters to encourage the development of their careers. A program chairing committee consisting of twelve members will select the winners based on quality of data and the novelty and significance of concepts presented. This application is being submitted to request educational grant funding for the 2002 Levine Symposium in Diabetes.